ALDX · Aldeyra Therapeutics, Inc. · Documents
Market Cap
$70.88M
Shares
60.33M
Volume · Oct 5
7.03M
Avg daily vol (3M)
1.04M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-29 | — | |
| 10-Q | 2026-08-06 | 2026-06-30 | |
| 8-K | 2026-07-30 | 2026-07-28 | |
| 8-K | 2026-07-15 | 2026-07-14 | |
| 8-K | 2026-06-10 | 2026-06-09 | |
| Investor Event Transcript | 2026-06-04 | 2026-06-30 | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-01 | — | |
| DEF 14A | 2026-04-27 | 2025-06-10 | |
| 8-K | 2026-04-20 | — | |
| 8-K | 2026-04-01 | — | |
| 8-K | 2026-03-17 | — | |
| 10-K | 2026-02-27 | 2025-12-31 | |
| 8-K | 2025-12-31 | 2025-12-23 | |
| 8-K | 2025-12-16 | 2025-12-15 | |
| 8-K | 2025-11-13 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-28 | — | |
| 8-K | 2025-08-19 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-11 | 2025-06-10 | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-06 | 2025-05-05 | |
| DEF 14A | 2025-04-25 | 2025-06-10 | |
| 8-K | 2025-04-17 | — | |
| 8-K | 2025-04-03 | — | |
| 10-K/A | 2025-03-28 | 2024-12-31 | |
| 10-K | 2025-02-28 | 2024-12-31 | |
| 8-K | 2024-11-18 | 2024-11-15 | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-10-03 | — | |
| 8-K | 2024-10-02 | 2024-09-30 | |
| 8-K | 2024-09-03 | 2024-08-29 | |
| 8-K | 2024-08-08 | — | |
| 8-K | 2024-08-01 | — | |
| 10-Q | 2024-08-01 | 2024-06-30 | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-06-13 | — | |
| 8-K | 2024-06-07 | 2024-06-04 | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| 8-K | 2024-04-25 | — | |
| DEF 14A | 2024-04-22 | 2024-06-04 | |
| 8-K | 2024-03-28 | — | |
| 10-K | 2024-03-07 | 2023-12-31 | |
| 8-K | 2024-02-13 | — | |
| 8-K | 2024-01-04 | — | |
| 8-K | 2023-12-21 | — |
Showing 1–50 of 128 filings